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Abstract: N-acetylneuraminic acid (Neu5Ac) represents the most common terminal 
carbohydrate residue in many mammalian glycoconjugates and is directly involved in a 
number of different physiological as well as pathological cellular processes. Endogenous 
sialic acids derive from the biosynthetic precursor molecule N-acetyl-D-mannosamine 
(ManNAc). Interestingly, N-acyl-analogues of D-mannosamine (ManN) can also be 
incorporated and converted into corresponding artificial sialic acids by eukaryotic cells. 
Within this study, we optimized a protocol for the chemical synthesis of various 
peracetylated ManN derivatives resulting in yields of approximately 100%. Correct 
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molecular structures of the obtained products ManNAc, N-propanoyl-ManN (ManNProp) 
and N-butyl-ManN (ManNBut) were verified by GC-, ESI-MS- and NMR-analyses. By 
applying these substances to human umbilical vein endothelial cells (HUVECs), we could 
show that each derivative was metabolized to the corresponding N-acylneuraminic acid 
variant and subsequently incorporated into nascent glycoproteins. To investigate whether 
natural and/or artificial sialic acid precursors are able to modulate the angiogenic capacity 
of HUVECs, a spheroid assay was performed. By this means, an increase in total capillary 
length has been observed when cells incorporated N-butylneuraminic acid (Neu5But) into 
their glycoconjugates. In contrast, the natural precursor ManNAc inhibited the growth of 
capillaries. Thus, sialic acid precursors may represent useful agents to modulate blood 
vessel formation. 
Keywords: glycoengineering; artificial sialic acids; mannosamine; angiogenesis 
 
1. Introduction 
Sialic acids are commonly found as terminal residues of carbohydrate moieties of both 
glycoproteins as well as glycolipids [1–3]. During the last decades, many studies have elucidated these 
acidic monosaccharides to be crucially involved in different biological processes [4]. In this context, 
for example, sialylLewisX-dependent homing of leukocytes via selectins represents one of the best 
characterized mechanisms [5]. 
Endogenous biosynthesis of N-acetylneuraminic acid (Neu5Ac) is based on the phosphorylation of 
the precursor molecule N-acetyl-D-mannosamine (ManNAc) and its subsequent conjugation with 
pyruvate (Figure 1) [1–3]. Subsequent activation of Neu5Ac takes place in the nucleus resulting in the 
formation of CMP-Neu5Ac. After its active transport into the Golgi network, biosynthesis of sialylated 
glycoconjugates is completed by transfer of Neu5Ac to both nascent glycoproteins and glycolipids. 
Intriguingly, enzymes involved in the cellular sialic acid metabolism are also known to metabolize 
artificial sialic acid intermediates that possess elongated acyl chains at their amino groups. Thus, 
metabolic glycoengineering represents a powerful strategy to modulate interactions which depend 
upon the presence of sialic acids [6]. 
So far, multiple approaches have been exploited to insert N-acylneuraminic acids (Neu5R) into 
various cell lines (Figure 1) [7]. Due to the substrate specificity of the key enzyme uridinediphospho-
N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE/MNK), that displays a striking 
specificity for physiological UDP-GlcNAc, chemically modified glucosamine analogues ended up to 
be poor candidates for sialo-engineering [6]. An alternative strategy is represented by the use of 
Neu5Ac or CMP-Neu5Ac analogues, since these components do not have to undergo substantial 
structural changes. However, their synthesis is not standardized yet, and, moreover, sialic acids are 
very expensive. Further studies indicated D-mannosamine (ManN) to be a more suitable target for 
chemical modification, since it is the common precursor of all sialic acids, it is very stable and can be 
easily modified [8]. Furthermore, overall cellular sialylation is mainly regulated by allosteric feedback 
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inhibition of GNE [6]. Since addition of N-acyl-ManN evades this checkpoint, levels of artificial sialic 
acids increase proportional to the amount of ManN derivatives applied [7]. 
Figure 1. Biosynthetic pathway of sialic acids and feasible implementations of artificial 
precursors. R, acyl chains; GNE/MNK, uridinediphospho-N-acetyl-glucosamine-2-
epimerase/N-acetylmannosamine kinase; NANS, N-acetylneuraminic acid synthase; 
NANP, N-acylneuraminate-9-phosphatase. 
 
In terms of their biological functions, sialic acids on endothelial cells were also reported to 
influence the initiation of lumen formation in developing blood vessels [9]. To investigate the impact 
of artificial sialic acids on capillary sprouting, human umbilical vein endothelial cells (HUVECs) were 
treated with ManNAc or artificial sialic acid precursors and respective capillary sprouting was 
analyzed after stimulation with basic fibroblast growth factor (bFGF). 
2. Results and Discussion 
2.1. Synthesis of Artificial Sialic Acid Precursors 
ManNAc, N-propionyl-ManN (ManNProp) and N-butyl-ManN (ManNBut) were generated on the 
basis of published protocols [8]. However, we divided the synthesis into three independent reaction 
steps to increase the overall yields (Figure 2A), since in our hands only 50% of ManN was converted 
into the respective artificial sialic acid precursors, when the published protocol was employed. At first, 
ManN was incubated with respective anhydrides of acetic acid, propionic acid and butyric acid 
resulting in the modification of both the hydroxyl groups and the amino group. Subsequently, mild 
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alkaline conditions removed the acyl chains from the hydroxyl groups leaving the modified amino 
residue untouched. Finally, addition of acetic acid anhydride resulted in the generation of  
per-O-acetylated ManNR derivatives that are able to penetrate cellular membranes due to their highly 
hydrophobic characteristics. Based on the presence of nonspecific cytoplasmatic esterases,  
O-acetyl-groups are cleaved resulting in the formation of respective N-acyl-ManN derivatives. 
Figure 2. Chemical synthesis of peracetylated N-acyl-ManN derivatives. (A) Reaction 
sequence including peracylation, cleavage of O-acyl-residues and peracetylation. GC analyses 
were performed to confirm the synthesized structures to be peracetylated (B) ManNAc,  
(C) ManNProp, and (D) ManNBut by comparing respective retention times to those of  
(E) standard substances, which were confirmed by NMR analysis. Further structural verification 
was performed by ESI-MS analyses of peracetylated (F) ManNAc, (G) ManNProp, and 
(H) ManNBut registered as sodium adducts ([M+Na]+) as well as sodium adducts after the 
loss of acetic acid. Hydrogen adducts ([M+H]+) formed after the loss of acetic acid are 
marked by trianglels (▼) and unidentified signals are labeled by asterisks (*). Retention 
times as well as monoisotopic masses are assigned with the first decimal place. 
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The accurate synthesis of artificial sialic acids was verified by gas chromatography (GC, Figure 2B–E), 
electrospray ionization-mass spectrometry (ESI-MS, Figure 2F–H), and NMR analyses (cf. Experimental 
Section). In comparison to retention times of standard substances, GC profiles of respective  
N-acyl-ManN derivatives revealed the presence of the α-anomer (first peak) as well as the β-anomer 
(second peak) of per-O-acetylated ManNAc, ManNProp and ManNBut (Figure 2B–D), thus 
demonstrating the successful synthesis of all derivatives to work under the conditions described. 
Corresponding ESI-MS analyses resulted in the predominant detection of sodium adducts ([M+Na]+) 
of particular derivatives at m/z 412.2, 426.2 and 440.2 (Figure 2F–H). Further fragmentation of 
selected adducts in ESI-MS2 experiments verified the annotations described above (data not shown). 
By using this step-by-step protocol for the synthesis of artificial sialic acids, no additional 
purification steps were needed. The protocol has been proven to work well for amounts of up to  
250 µg per preparation and the calculated yield was approximately 100%. The given values for 
temperature and pH as well as anhydrous conditions, however, have to be followed closely during the 
entire synthesis procedure. Otherwise, an epimerization of ManN into glucosamine takes place 
preventing successful synthesis of N-acyl-ManN derivatives (data not shown). 
2.2. Integration of Artificial Sialic Acids into Glycoconjugates in HUVECs 
The synthesized substances were applied to the cell culture medium of HUVECs with a final 
concentration of 50 µM per ManNR derivative. At first, the biocompatibility of all generated components 
was determined. For this purpose, the release of lactate dehydrogenase (LDH) was compared with 
untreated cells. In agreement with other studies, concentrations of 50 µM had no significant effect on 
the cell behavior (Figure 3) allowing a treatment of HUVECs with all ManNR derivatives [10,11]. 
Figure 3. Biocompatibility of peracetylated ManNProp, ManNBut, and ManNAc. HUVECs 
were incubated with 50 µM of per-O-acetylated ManNProp, ManNBut, and ManNAc for 
48 h and supernatants were checked for LDH activity. 100% was set for Triton-X 100 (1% v/v) 
treated HUVECs. All values ± S.D. in this figure are means of 3 independent experiments. 
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Using a LC-ESI-MS(/MS) approach of total cell lysate we wanted to analyze whether each 
derivative was converted into the corresponding Neu5R analogue (Figure 4). For this purpose, cells 
were homogenized, sialic acids present were fluorescently labeled with 1,2-diamino-4,5-methylene-
dioxybenzene (DMB) and generated reaction products were separated by RP-HPLC (Figure 4A). 
Comparison of retention times of registered signals with those of standard substances revealed Neu5Ac 
to be also present in HUVECs incubated with ManNProp and ManNBut (marked with a blue and 
yellow rectangle, respectively). In addition, peaks at 29.5 min (red rectangle) and 37.0 min (green 
rectangle) indicated the presence of Neu5Prop and Neu5But, respectively. Cells incubated exclusively 
with ManNAc provided a single signal for Neu5Ac. Extracted ion chromatograms (EIC) of m/z values 
corresponding to sodium adducts ([M+Na]+) of respective artificial sialic acids confirmed the presence 
of Neu5Ac (m/z 448) and Neu5Prop (m/z 462) as well as Neu5But (m/z 476) (Figure 4B). ESI-MS/MS 
analyses of selected precursor ions registered as hydrogen adducts ([M+H]+) provided the characteristic 
fragmentation pattern of DMB-labeled sialic acids as proposed elsewhere [11,12] (Figure 4C, 
respective signals printed in bold). Sialic acid precursor ions formed after loss of water were selected 
for these fragmentation analyses (Neu5Ac-H20, m/z 408.1; Neu5Prop-H20, m/z 422.1 and Neu5But-H20, 
m/z 436.2). 
Exemplarily, the structure of Neu5Ac prior to loss of water is given in the inset of the upper profile. 
Next to the detection of fragment ions of identical m/z values (m/z 216.9, 228.9, 283.0, 301.0, 313.0, 
331.1 and 349.1), whose generation was based on fragmentation pathways within which the N-acyl 
side chain is lost, signals at m/z 270.0 in case of Neu5Ac and corresponding signals at m/z 284.0 and 
298.0 in case of Neu5Prop and Neu5But indicated cross-ring fragmentations within the DMB moiety, 
thus leaving the N-acyl-side chain of respective artificial sialic acids intact. In a similar way, fragment 
ions at m/z 390.1, 404.1 and 418.1 reflected the loss of water from respective parent ions. 
These results revealed that chemically synthesized peracetylated ManNProp and ManNBut were 
incorporated by HUVECs and subsequently transformed into Neu5Prop and Neu5But, respectively.  
To determine whether these artificial sialic acids are also incorporated into nascent glycoproteins, 
HUVECs were incubated with ManNAc, ManNProp and ManNBut followed by isolation of 
glycoproteins and the analysis of the attached sialic acid residues (Figure 5). RP-HPLC analyses of 
DMB-labeled sialic acids present in cellular glycoproteins provided equal results compared to 
respective analyses of total cell lysates (Figure 5A; cf. Figure 4A). Peaks representing Neu5Prop and 
Neu5But were detectable at 29.0 min and 36.8 min, respectively. ESI-MS(/MS) identified these Neu5R 
analogues by registration of their sodium adducts ([M+Na]+) in EIC of m/z 462 and 476 (Figure 5B) as 
well as by displaying the characteristic fragmentation pattern of respective precursor molecules  
(Figure 5C). These findings demonstrated that incorporation of artificial sialic acid precursors into 
glycoproteins takes place resulting in an alteration of cell sialylation in vitro. 
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Figure 4. Analysis of sialic acids present in whole cell lysate from HUVECs treated with 
peracetylated ManNProp, ManNBut, and ManNAc. (A) DMB-labeled sialic acid residues 
were separated by RP-HPLC. For control, HUVECs were not incubated with any sialic 
acid precursors. (B) EIC of sodium adducts ([M+Na]+) of Neu5Ac (m/z 448) and 
Neu5Prop (m/z 462) as well as Neu5Ac (m/z 448) and Neu5But (m/z 476) present in 
HUVECs incubated with peracetylated ManNProp and ManNBut, respectively. Peaks 
related to DMB reagent are labeled with an asterisk (*) and those related to further 
unidentified impurities are marked with a triangle (▼). (C) ESI-MS/MS analyses of 
Neu5Ac (upper profile), Neu5Prop (central profile) and Neu5But (lower profile) are 
registered as proton adducts ([M+H]+). For fragmentation analyses, respective parent ions 
generated after loss of water were selected. Annotation of fragment ions was performed 
according to the fragmentation pathway of DMB-labeled sialic acids proposed by Manzi 
and co-workers [12] with monoisotopic masses of respective fragment ions printed in bold. 
Corresponding structures of generated fragments are given exemplarily in the upper 
profile. For the structure of Neu5Ac (m/z 426.1) prior to loss of water see inset. 
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Figure 5. Analysis of sialic acid residues of glycoproteins isolated from HUVECs after 
incubation with per-O-acetylated ManNProp, ManNBut, and ManNAc. (A) Sialic acid 
residues obtained after DMB-labeling were separated by RP-HPLC. For control, HUVECs 
were not incubated with any sialic acid precursors. Peaks related to DMB reagent are 
labeled with an asterisk (*) and those related to unknown impurities are marked with a 
triangle (▼). (B) EIC of sodium adducts ([M+Na]+) of Neu5Prop (m/z 462) and Neu5But 
(m/z 476) present in glycoproteins from HUVECs incubated with ManNProp and 
ManNBut, respectively. (C) ESI-MS/MS analyses of Neu5Prop (upper profile) and 
Neu5But (lower profile) registered as proton adducts ([M+H]+). Annotation of fragment 
ions was carried out as defined in Figure 4. 
 
2.3. Artificial Sialic Acids Influence Capillary Sprouting of HUVECs 
By use of a spheroid assay we wanted to elucidate whether the observed alteration in cell sialylation 
also affects physiological functions of endothelial cells such as vessel formation. To this end, cells 
were incubated with per-O-acetylated ManNR derivatives, stimulated with bFGF and arising capillary 
lengths were measured and compared with unstimulated spheroids (Figure 6). Surprisingly, the results 
demonstrated that sprouting of spheroids–treated with the natural sialic acid precursor ManNAc–was 
significantly inhibited. ManNAc caused a reduction of total capillary length by 75% of the values 
obtained for spheroids, which were not co-stimulated with sialic acid precursors. After ManNProp 
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treatment, however, the sprouting capability of HUVEC spheroids was similar to the control spheroids. 
Intriguingly, ManNBut treatment significantly enhanced capillary sprouting of HUVECs after bFGF 
stimulation. The total capillary length was 50% higher in comparison to spheroids, which were not 
incubated with any ManNR derivate. 
Figure 6. Influence of per-O-acetylated ManNR derivatives on capillary sprouting of 
endothelial cell spheroids induced by bFGF. (A) Scheme of the applied three dimensional 
angiogenesis assay. HUVECs spheroids were treated with bFGF to induce capillary 
sprouting in absence (control) or presence of indicated sialic acid precursor molecules  
(R, acyl chains) [13,14]. (B) Representative spheroids after bFGF stimulation. (C) The 
lengths of arising capillaries were measured and obtained values were summed up using 
NIS Elements AR 3.0 Software (Nikon, Düsseldorf, Germany). Results are shown as 
relative increase in total capillary length after stimulation with bFGF. To this end, total 
capillary lengths of spheroids were measured after bFGF stimulation and compared with 
the unstimulated control. All values ± S.D. in this figure are means of 3 independent 
experiments using at least 12 spheroids per set. The statistical evaluation was performed by 
Student´s t test (unequal variances, two tailed). Significance levels are indicated by n.s. 
(not significant), p > 5%; *, p < 5%; **, p < 1%; ***, p < 0.1%. 
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The relative increase in total capillary length in endothelial cell spheroids incubated with ManNBut 
might be induced by its structural differences compared to ManNAc. Therefore, one may suggest that 
the additional ethylene group in its elongated acyl-chain impedes the interaction of Neu5But with 
accessory enzymes or carbohydrate-binding receptors, which are involved in the formation of blood 
vessels. For example, glycosylation of integrins and fibroblast growth factor receptors is essential for 
their biological functions [15–17]. Consequently, not only the negative charge of sialic acids might be 
necessary for the regulation of blood vessel formation as already mentioned before [9], but also a 
specific recognition of Neu5Ac could be involved. 
In addition to glycoproteins, however, formation and relative proportions of different gangliosides 
like GD3 and GM3 are important for angiogenic processes and might be disturbed by administration of 
ManNAc and/or artificial sialic acid precursors [18,19]. In the case of GD3, for example, an  
α2,8-sialyltransferase activity is necessary for the generation of this ganglioside. Other groups could 
show that some α2,8-sialyltransferases can be stimulated by ManNAc or inhibited by ManNProp and 
ManNBut [20,21]. 
Apart from the sialome of the HUVEC surface, also intracellular signaling might be influenced by 
the application of ManNR derivates. The intracellular CMP-Neu5Ac level is discussed to affect cell 
proliferation, gene expression as well as phosphorylation of intracellular signaling molecules like the 
extracellular signal-regulated kinase ERK [22]. The impact of artificial CMP-Neu5R derivatives, 
however, has not been addressed in this context so far. Furthermore, ManNR can be partially 
converted to GlcNR [23]. Thus, intracellular O-GlcNAc-ylation might be also changed leading to an 
inhibition of phosphorylation [24]. Taken together, we could show that ManNR derivatives influence 
the angiogenic capacity of HUVECs. The precise role of the applied substances during sprouting 
processes, however, needs to be further investigated. 
3. Experimental 
3.1. Chemicals and Reagents 
The monosaccharide standards ManN, Neu5Ac, Neu5Gc and 2- keto-3-deoxy-d-glycero-d-galacto-
nononic acid (KDN) were purchased from Sigma-Aldrich (Taufkirchen, Germany). All reagents used 
were of analytical grade. 
3.2. Synthesis of Ac4-ManN Derivatives 
ManN hydrochloride (250 µg) was peracylated by incubation with pyridine (100 µL) and respective 
carbonic acid anhydride (acetic acid, propionic acid and butyric acid for the synthesis of ManNAc, 
ManNProp and ManNBut, respectively, 300 µL) at 37 °C overnight. To specifically remove  
O-acyl-chains while maintaining N-acylation, samples were dried down under a stream of nitrogen and 
dissolved in 0.01 M methanolic NaOH (500 µL) at 0 °C for 2 h. Subsequently, samples were frozen in 
liquid nitrogen and lyophilized overnight. Peracetylation of hydroxyl-groups was achieved by 
incubation with pyridine (100 µL) and ethanoic anhydride (300 µL) overnight at room temperature. 
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3.3. Cell Culture 
Isolation of HUVECs was carried out using the method described by Minick and co-workers [25] 
(approved by the local research ethics committee (No. 132/09). Cells were cultivated with endothelial 
cell growth medium (ECGM; Promocell, Heidelberg, Germany) containing 10% fetal calf serum (FCS; 
Thermo Fisher Scientific, Bonn, Germany) (v/v) in the absence or presence of sialic acid precursor 
molecules (50 mM). After three washing steps with PBS, cells were harvested using a cell scraper to 
protect surface glycoproteins from lysis by trypsine. Subsequently, cells were homogenized in 10 mM 
Tris/HCl-buffer (pH 8.0) containing 1% Triton-X 100 (v/v) using an ultrasonic dispersor. Cytotoxicity 
was determined with the LDH cytotoxicity assay (Roche Applied Science, Mannheim, Germany) 
according to the instructions of the manufacturer. 
3.4. Sample Preparation for the Analysis of Sialic Acids 
To distinguish between cytosolic sialic acid derivatives and those actually incorporated into 
glycoproteins one aliquot of the homogenized cells was dried down and subjected to sialic acid 
analysis. Remaining sample was mixed thoroughly with chloroform:methanol (1:2, v/v, 600 µL). After 
centrifugation, both the chloroform and the methanol phase were discarded. The obtained interphase, 
containing cellular proteins, was homogenized in ice cold 90% ethanol and dried for sialic acid analyses. 
3.5. DMB-Labeling of Sialic Acids 
For fluorescent labeling, samples were hydrolyzed in 2 M acetic acid (200 µL) for 90 min at 80 °C 
and dried down. Subsequently, samples were dissolved in DMB-reaction buffer [80 µL, 7 mM DMB 
(Dojindo, Kumamoto, Japan), 500 mM 2-mercaptoethanol, 9 mM sodium hydrosulfite, 20 mM 
trifluoroacetic acid (TFA)] and incubated for 2 h at 55 °C [26,27]. Reaction was stopped by adding  
0.2 M NaOH (20 µL). 
3.6. HPLC-Separation 
DMB-labeled samples were analyzed on a Superspher 100 C-18 column (250 mm × 40 mm,  
Merck-Hitachi, Darmstadt, Germany) at 40 °C using a Knauer HPLC system. Mobile phases M1 
[methanol/acetonitrile(AcN)/water/TFA = 4:4:92:0.1 (v/v/v)] and M2 [methanol/AcN/water/TFA = 
45:45:10:0.1, v/v/v) were used for their separation. A linear gradient was applied from 0% to 100% 
M2 in 35 min at a flow rate of 0.25 mL/min. A fluorescence detector (Merck-Hitachi, Darmstadt, 
Germany) was set at 372 nm for excitation and 456 nm for emission. 
3.7. GC (-MS) Analyses 
Samples were separated on a 60 m RTx 5MS column (Restek GmbH, Bad Homburg Germany) 
using a Varian Star 3400 gas chromatograph (Agilent, Santa Clara, CA, USA). To this end, samples 
were injected manually at an injector temperature of 270 °C. Starting from an initial column 
temperature of 130 °C for 1 min, a temperature gradient of 5 °C/min was applied up to a maximum 
temperature of 290 °C, which was maintained for 10 min before cooling down. Detection was carried 
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out by a flame ionization detector at 300 °C. GC-MS analyses were performed on a Polaris Q 
instrument (Thermo Scientific, Dreieich, Germany). To this end, samples were separated on a 60 m VF 
5MS column (Agilent) using the following conditions: T0 min = 50 °C, T1.88 min = 50 °C, T4.63 min = 160 °C, 
T 28.63 min = 280 °C, and T 30 min = 280 °C. For GC and GC-MS analyses helium 5.6 was used as carrier 
gas. GC and GC-MS data were processed and analyzed with EuroChrom Software (Knauer) and 
Xcalibur Software (Thermo Scientific), respectively. 
3.8. nanoLC-ESI-MS(/MS)-Analysis 
Ten µL of sample was separated on a RP-column (PepMap, 3 µm spheres 75 µm × 100 mm, LC 
Packings) using an Ultimate nanoLC system. Mobile phases M1 [AcN/water/formic acid = 8:92:0.1 
(v/v/v)] and M2 [AcN/water/formic acid = 90:10:0.1 (v/v/v)] were used for separation with a linear 
gradient from 0% to 20% M2 in 30 min at a flow rate of 0.3 µL/min. The Ultimate nanoLC system was 
directly coupled with an Esquire 3000 ESI-ion trap-MS (Bruker Daltonics, Bremen, Germany) 
operated with spray voltage of 1.4 kV, capillary temperature of 250 °C, end plate offset of -500V, and 
capillary exit of 140V. Recorded MS data were processed and analyzed using DataAnalysis Software 
(Bruker Daltonics). 
3.9. NMR-Analysis 
The molecular structures of the obtained products ManNAc, N-propanoyl-ManN (ManNProp) 
and N-butyl-ManN (ManNBut) were verified by 1H-NMR spectroscopy. To obtain the complete 1H 
chemical shift assignments the structure elucidation was based on the application of homonuclear 
1H,1H correlation spectroscopy (COSY and TOCSY) and heteronuclear 1H,13C-correlation 
spectroscopy (edited-HSQC and HMBC). All one-dimensional and two-dimensional NMR experiments 
were performed on a Bruker Avance III 600 spectrometer equipped with a 5 mm BBO Z-gradient 
probe.The data were collected and processed by TOPSPIN software (Bruker) running on a PC with 
Microsoft WindowsXP. The NMR experiments were performed using Bruker standard pulse sequences 
and parameters. Chemical shifts are reported in ppm ( scale) using the solvent signal as standard and 
coupling constants (J) are reported in Hz. Multiplicities of NMR signals are designated as s (singlet), d 
(doublet), t (triplet), q (quartet), br (broad), m (multiplet, for unresolved lines), etc. ManNAc,  
N-propanoyl-ManN (ManNProp) and N-butyl-ManN (ManNBut) gave acceptable 1H-NMR spectra 
that matched the data reported in the cited references [15–17]. The one-bond 13C, 1H coupling 
constant 1J(13C,1H) for the anomeric proton was used as a supplement to the chemical shift data for 
the assignment of the anomeric structure of ManNAc and ManNProp [18]. 
ManNAc. 1H-NMR (acetone-d6):  (mixtures of anomers) (-isomer)  7.59 (d, 1H, JNH,H-2 9.2 Hz, 
NH), 5.97 (d, 1H, J1,2 1.8 Hz, 1JH-1,C-1 177.6 Hz, H-1), 5.27 (m, 1H, H-3), 5.23 (m, 1H, H-4), 4.58 (m, 
1H, H-2), 4.01–4.15 (m, 2H, H-6,6′), 4.10 (m, 1H, H-5); (-isomer) 7.40 (d, 1H, JNH,H-2 9.5Hz, NH), 
5.97 (d, 1H, J1,2 1.9 Hz, 1JH-1,C-1 166.7 Hz, H-1), 5.16 (m, 1H, H-3), 5.14 (m, 1H, H-4), 4.77 (m, 1H,  
H-2), 4.06–4.17 (m, 2H, H-6,6′), 3.97 (m, 1H, H-5), 2.20–1.90 (s, -CH3, Ac). 
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N-Propanoyl-ManN (ManNProp). 1H-NMR (acetone-d6):  (mixtures of anomers) (-isomer) 7.48 
(d, 1H, JNH,H-2 8.8 Hz, NH), 5.96 (d, 1H, J1,2 1.8 Hz, 1JH-1,C-1 176.6 Hz, H-1), 5.28 (m, 1H, H-3), 5.26 
(m, 1H, H-4), 4.60 (m, 1H, H-2), 4.02–4.17 (m, 2H, H-6,6′), 4.10 (m, 1H, H-5), 2.25 (q, -CH2-, Pr), 
2.17, 2.04, 1.98, 1.93 (s, -CH3, Ac), 1.07 (t, -CH3, Pr); (-isomer) 7.29 (d, 1H, JNH,H-2 9.8 Hz, NH), 
5.98 (d, 1H, J1,2 2.0 Hz, 1JH-1,C-1 167.8 Hz, H-1), 5.17 (m, 1H, H-3), 5.16 (m, 1H, H-4), 4.79 (m, 1H,  
H-2), 4.07–4.19 (m, 2H, H-6,6′), 3.92 (m, 1H, H-5), 2.25 (q, -CH2-, Pr), 2.17, 2.04, 1.98, 1.93 (s, -CH3, 
Ac), 1.07 (t, -CH3, Pr). 
N-Butyl-ManN (ManNBut). 1H-NMR (acetone-d6):  7.30 (d, 1H, JNH,H-2 9.4 Hz, NH), 5.98 (d, 1H, J1,2 
1.9 Hz, H-1), 5.18 (m, 1H, H-3), 5.17 (m, 1H, H-4), 4.79 (m, 1H, H-2), 4.06–4.18 (m, 2H, H-6,6′), 
3.98 (m, 1H, H-5), 2.21 (t, 2H, -CH2-, Bu), 2.04, 2.03, 2.00, 1.92 (s, 3H, Ac), 1.63 (m, 2H,  
-CH2-, Bu), 0.93 (t, 3H, -CH3, Bu). 
3.10. Spheroid Assay 
Endothelial cell spheroids were generated as described by Korff and Augustin [16]. To this end, 
HUVECs were suspended in ECGM containing 20% methylcellulose (w/v) (Sigma-Aldrich, München, 
Germany) and 3,000 cells per well were cultivated under non-adhesive conditions in round bottom  
96-well plates (Greiner Bio One, Frickenhausen, Germany) for 18–24 h at 37 °C. Spheroid assay was 
performed according to the micro-bead angiogenesis protocol as described previously [16,17]. 
Fibrin matrix was prepared as described by Orci and co-workers [17]. Bovine fibrinogen 
(Calbiochem/Merck Millipore, Darmstadt, Germany) was dissolved in PBS, pH 7.4. This stock 
solution was adjusted to a final concentration of 1.8 mg/mL in Dulbeccos PBS, pH 7.4 (Invitrogen, 
Karlsruhe, Germany), and 200 U/mL of protease inhibitor Trasylol (Bayer, Leverkusen, Germany) 
were added. Spheroids were harvested, washed and a sufficient volume was transferred to the 
fibrinogen solution in 24-well plates (Corning, Wiesbaden, Germany). Fibrinogen was polymerized by 
the addition of 0.65 U/mL thrombin (Sigma-Aldrich). Gels were equilibrated for 30 min at 37 °C with 
endothelial basal medium (Promocell) containing 0.5% (v/v) FCS. On replacement with fresh medium, 
test substances together with bFGF were added and the plates were incubated for 48–72 h at 37 °C. 
Subsequently, cells were fixed with 4% paraformaldehyde (w/v) and stored at 4 °C. 
4. Conclusions 
The outermost position of sialic acids in glycoproteins and glycolipids makes them accessible to 
numerous cellular communication elements involved in the formation of contacts with components of 
the same or neighboring cell, with extracellular matrix or invading pathogens [4]. So far, many studies 
have provided evidence that the application of artificial sialic acids represents a promising tool to 
modulate such sialic acid-dependent processes. For example, elongated N-acyl side chains of sialic 
acids have been shown to provide protection against an infection with influence virus A in vitro [28]. 
Recently, it has also been demonstrated that the presence of artificial sialic acids on glycoproteins may 
affect their resistance to sialidases [29]. Thus, biological half-life of therapeutic glycoproteins might be 
efficiently increased also in vivo. 
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In this study, we describe an optimized protocol for the synthesis of artificial sialic acid precursors 
and, furthermore, demonstrate that endothelial cells metabolize these glycoengineered monosaccharides 
and incorporate the resulting modified sialic acids into their cellular glycoproteins. Intriguingly, 
natural sialic acid precursors inhibited the angiogenic capacity of HUVECs. Hence, administration of 
natural sialic acid precursors might be a useful tool to inhibit angiogenesis in cancer patients.  
In contrast, Neu5But precursors led to an extended bFGF-mediated capillary sprouting of HUVECs. 
Thus, ManNBut could represent a suitable agent to stimulate blood vessel formation during,  
e.g., wound healing processes. However, further in vitro tests including a migration assay, vascular 
endothelial growth factor (VEGF) induced sprouting and tube formation assays as well as in vivo 
models are required to evaluate the biomedical potential of ManNR derivates during angiogenic 
processes and to study the exact mechanisms leading to the observed modulation of angiogenesis. 
Taken together, sialic acid glycoengineering offers numerous possibilities to influence 
physiological processes, but the resulting biological activities have to be carefully assessed to exclude 
undesired side effects. 
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